T. An

F. Tang, Zhaoli Chen, Shuhang Wang, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

541例女性晚期非小细胞肺癌患者的预后因素分析

H. Bai, M. Zhuo, J. Duan, 2011, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Influence of body mass index on the therapeutic efficacy of gemcitabine plus cisplatin and overall survival in lung squamous cell carcinoma

Shuhang Wang, Hanxiao Chen, M. Zhuo, 2018, Thoracic cancer.

Prediction of the VeriStrat test in first-line therapy of pemetrexed-based regimens for advanced lung adenocarcinoma patients

J Zhang, Hanxiao Chen, Qingwei Ma, 2020, Cancer cell international.

A nomogram model to predict death rate among non-small cell lung cancer (NSCLC) patients with surgery in surveillance, epidemiology, and end results (SEER) database

Hanxiao Chen, M. Zhuo, Jun Zhao, 2020, BMC Cancer.

血清肿瘤标志物与一线EGFR-TKIs治疗晚期EGFR突变型肺腺癌患者疗效相关性分析

Hanxiao Chen, M. Zhuo, Jun Zhao, 2017, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Malignant pleural effusion cell blocks are substitutes for tissue in EML4‐ALK rearrangement detection in patients with advanced non‐small‐cell lung cancer

Xianxin Li, X. Li, H. Bai, 2016, Cytopathology : official journal of the British Society for Clinical Cytology.

[The Association between EGFR Gene Amplification and the Prognosis in Non-small Cell Lung Cancer: A meta-analysis.].

H. Bai, J. Duan, Zhijie Wang, 2009, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

[Clinical Efficacy of Crizotinib in Treatment of Patients with Advanced NSCLC].

M. Zhuo, Zhijie Wang, Jun Zhao, 2016, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Correlation among genetic variations of c-MET in Chinese patients with non-small cell lung cancer

H. Bai, M. Zhuo, J. Duan, 2017, Oncotarget.

Correlation among Genetic Variations of c-MET in Chinese Patient with Non-Small Cell Lung Cancer

H. Bai, M. Zhuo, J. Duan, 2017 .

The prevalence and real‐world therapeutic analysis of Chinese patients with KRAS‐Mutant Non‐Small Cell lung cancer

Hanxiao Chen, M. Zhuo, Jun Zhao, 2022, Cancer medicine.

[Primary lung cancer with gastrointestinal metastasis: 2 case report and literature review].

M. Zhuo, J. Duan, Zhijie Wang, 2011, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Nomogram model for predicting cause-specific mortality in patients with stage I small-cell lung cancer: a competing risk analysis

Hanxiao Chen, M. Zhuo, Jun Zhao, 2019, BMC Cancer.

A Novel Third-generation EGFR Tyrosine Kinase Inhibitor Abivertinib for EGFR T790M-mutant Non–Small Cell Lung Cancer: a Multicenter Phase I/II Study

Ying Cheng, Yi-long Wu, B. Han, 2021, Clinical cancer research : an official journal of the American Association for Cancer Research.

[Characteristics and treatment of bone metastases in 322 cases non-small cell lung cancer: a retrospective study].

Shuhang Wang, J. Duan, Zhijie Wang, 2014, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

ABCB1 polymorphism predicts the toxicity and clinical outcome of lung cancer patients with taxane‐based chemotherapy

Hanxiao Chen, M. Zhuo, Jun Zhao, 2019, Thoracic cancer.

Clinical features of patients with lung adenocarcinomas harboring BRAF V600E mutations.

Shuhang Wang, H. Bai, M. Zhuo, 2013 .

DNA Methylation status of Wnt antagonist SFRP5 can predict the response to the EGFR-tyrosine kinase inhibitor therapy in non-small cell lung cancer

Shuhang Wang, Jian Zhu, H. Bai, 2012, Journal of Experimental & Clinical Cancer Research.

[Primary assessment of treatment effect of thymosin alpha1 on chemotherapy-induced neurotoxicity].

T. An, Mei-na Wu, Xu-yi Liu, 2004, Ai zheng = Aizheng = Chinese journal of cancer.

Inferring the Evolution and Progression of Small-Cell Lung Cancer by Single-Cell Sequencing of Circulating Tumor Cells

X. Xie, Shuhang Wang, Ruoyan Li, 2019, Clinical Cancer Research.

Detection and Clinical Significance of Intratumoral EGFR Mutational Heterogeneity in Chinese Patients with Advanced Non-Small Cell Lung Cancer

Qinghua Zhou, H. Bai, M. Zhuo, 2013, PloS one.

Evolution and genotypic characteristics of small cell lung cancer transformation in non-small cell lung carcinomas

Yan Wang, Hanxiao Chen, Tiantian Gu, 2021, Journal of the National Cancer Center.

Potential Resistance Mechanisms Revealed by Targeted Sequencing from Lung Adenocarcinoma Patients with Primary Resistance to Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs)

Shuhang Wang, G. Zhu, H. Bai, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

High‐fidelity of non‐small cell lung cancer xenograft models derived from bronchoscopy‐guided biopsies

H. Bai, J. Duan, Zhijie Wang, 2015, Thoracic cancer.

Optimal first‐line treatment for advanced thymic carcinoma

Hanxiao Chen, M. Zhuo, Jun Zhao, 2019, Thoracic cancer.

ERβ localization influenced outcomes of EGFR-TKI treatment in NSCLC patients with EGFR mutations

Shuhang Wang, Zhirong Shen, H. Bai, 2015, Scientific Reports.

Phosphorylated EGFR expression may predict outcome of EGFR-TKIs therapy for the advanced NSCLC patients with wild-type EGFR

Shuhang Wang, H. Bai, J. Duan, 2012, Journal of experimental & clinical cancer research : CR.

Identification of plasma microRNA profiles for primary resistance to EGFR-TKIs in advanced non-small cell lung cancer (NSCLC) patients with EGFR activating mutation

Shuhang Wang, H. Bai, M. Zhuo, 2015, Journal of Hematology & Oncology.

Epidermal growth factor receptor variant III mutation in Chinese patients with squamous cell cancer of the lung

H. Bai, M. Zhuo, J. Duan, 2015, Thoracic cancer.

Clinical outcomes of EGFR-TKI treatment and genetic heterogeneity in lung adenocarcinoma patients with EGFR mutations on exons 19 and 21

H. Bai, J. Duan, Jun Zhao, 2016, Chinese journal of cancer.

Patients harboring epidermal growth factor receptor (EGFR) double mutations had a lower objective response rate than those with a single mutation in non‐small cell lung cancer when treated with EGFR‐tyrosine kinase inhibitors

H. Bai, M. Zhuo, J. Duan, 2014, Thoracic cancer.

Efficacy and Safety of Combination Treatment With Apatinib and Osimertinib After Osimertinib Resistance in Epidermal Growth Factor Receptor-Mutant Non-small Cell Lung Carcinoma—A Retrospective Analysis of a Multicenter Clinical Study

Hanxiao Chen, M. Zhuo, Jun Zhao, 2021, Frontiers in Molecular Biosciences.

Alterations in EGFR and Related Genes following Neo-Adjuvant Chemotherapy in Chinese Patients with Non-Small Cell Lung Cancer

Shuhang Wang, Qinghua Zhou, H. Bai, 2013, PloS one.

EML4-ALK Rearrangement and Its Clinical Significance in Chinese Patients with Advanced Non-Small Cell Lung Cancer

Shuhang Wang, Yilong Wu, H. Bai, 2012, Oncology.

Epidermal growth factor receptor mutations in plasma DNA samples predict tumor response in Chinese patients with stages IIIB to IV non-small-cell lung cancer.

L. Mao, H. Bai, Jun Zhao, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Toripalimab in an advanced non-small cell lung cancer patient with poor general condition after multiline treatment: a case report

T. An, Yuling He, 2021, The Journal of international medical research.

Clinical Characteristics and Outcomes of Patients With Primary Mediastinal Germ Cell Tumors: A Single-Center Experience

Hanxiao Chen, M. Zhuo, Jun Zhao, 2020, Frontiers in Oncology.

The Prognostic and Therapeutic Role of Genomic Subtyping by Sequencing Tumor or Cell-Free DNA in Pulmonary Large-Cell Neuroendocrine Carcinoma

P. A. Futreal, X. Yi, J. Roth, 2019, Clinical Cancer Research.

Potential Clinical Significance of a Plasma-Based KRAS Mutation Analysis in Patients with Advanced Non–Small Cell Lung Cancer

X. Wang, Shuhang Wang, H. Bai, 2010, Clinical Cancer Research.

EGFR mutations are associated with prognosis but not with the response to front-line chemotherapy in the Chinese patients with advanced non-small cell lung cancer.

Shuhang Wang, S. Song, H. Bai, 2010, Lung cancer.

Survival difference between EGFR Del19 and L858R mutant advanced non-small cell lung cancer patients receiving gefitinib: a propensity score matching analysis.

Shuhang Wang, Hanxiao Chen, M. Zhuo, 2017, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

Refined Stratification Based on Baseline Concomitant Mutations and Longitudinal circulating tumor DNA Monitoring in Advanced EGFR-mutant Lung Adenocarcinoma under Gefitinib Treatment.

Ying Cheng, Yi-long Wu, Yuankai Shi, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Detection of EGFR mutations in plasma circulating tumour DNA as a selection criterion for first-line gefitinib treatment in patients with advanced lung adenocarcinoma (BENEFIT): a phase 2, single-arm, multicentre clinical trial.

Ying Cheng, Yi-long Wu, Meizhuo Zhang, 2018, The Lancet. Respiratory medicine.

Analysis of EGFR mutation status in tissue and plasma for predicting response to EGFR-TKIs in advanced non-small-cell lung cancer.

Shuhang Wang, Hanxiao Chen, H. Bai, 2017, Oncology letters.

Quantification and Dynamic Monitoring of EGFR T790M in Plasma Cell-Free DNA by Digital PCR for Prognosis of EGFR-TKI Treatment in Advanced NSCLC

R. Chen, Shuhang Wang, H. Bai, 2014, PloS one.

The detection of EGFR mutation status in plasma is reproducible and can dynamically predict the efficacy of EGFR‐TKI

Shuhang Wang, H. Bai, M. Zhuo, 2012, Thoracic cancer.

Influence of chemotherapy on EGFR mutation status among patients with non-small-cell lung cancer.

Qinghua Zhou, Li Mao, Jun Zhao, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Analysis of BIM (BCL‐2 like 11 gene) deletion polymorphism in Chinese non‐small cell lung cancer patients

H. Bai, J. Duan, Jun Zhao, 2014, Thoracic cancer.

Immediate versus delayed treatment with EGFR tyrosine kinase inhibitors after first-line therapy in advanced non-small-cell lung cancer

T. Mok, Ping Yang, H. Bai, 2011, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

Quantification of mutant alleles in circulating tumor DNA can predict survival in lung cancer

H. Bai, M. Zhuo, J. Duan, 2016, Oncotarget.

Clinical outcome of epidermal growth factor receptor‐tyrosine kinase inhibitors therapy for patients with overlapping kirsten rat sarcoma 2 viral oncogene homolog and epidermal growth factor receptor gene mutations

H. Bai, Jun Zhao, T. An, 2015, Thoracic cancer.

DNA Methylation status of Wnt antagonist SFRP5 can predict the response to the EGFR-tyrosine kinase inhibitor therapy in non-small cell lung cancer

Lai Wei, Shuhang Wang, Jian Zhu, 2012, Journal of experimental & clinical cancer research : CR.

晚期非小细胞肺癌初始治疗后再次应用EGFR-TKI的疗效观察

H. Bai, Zhijie Wang, T. An, 2011, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Nomogram to predict cause‐specific mortality in extensive‐stage small cell lung cancer: A competing risk analysis

Hanxiao Chen, M. Zhuo, Jun Zhao, 2019, Thoracic cancer.

Safety and efficacy of abivertinib (AC0010), a third-generation EGFR tyrosine kinase inhibitor, in Chinese patients with EGFR-T790M positive non-small cell lung cancer (NCSLC).

Ying Cheng, Yi-long Wu, B. Han, 2019, Journal of Clinical Oncology.

[Gefitinib in the treatment of advanced non-small cell lung cancer].

T. An, Mei-na Wu, Lu Yang, 2006, Zhonghua zhong liu za zhi [Chinese journal of oncology].

Analysis of topoisomerase I expression and identification of predictive markers for efficacy of topotecan chemotherapy in small cell lung cancer

Hanxiao Chen, H. Bai, M. Zhuo, 2018, Thoracic cancer.

放Identification of serum biomarkers to predict pemetrexed/platinum chemotherapy efficacy for advanced lung adenocarcinoma patients by data-independent acquisition (DIA) mass spectrometry analysis with parallel reaction monitoring (PRM) verification

Xiaoling Chen, Hanxiao Chen, M. Zhuo, 2021, Translational lung cancer research.

Survival analysis via nomogram of surgical patients with malignant pleural mesothelioma in the Surveillance, Epidemiology, and End Results database

Hanxiao Chen, M. Zhuo, Jun Zhao, 2019, Thoracic cancer.

A phase II trial of gefitinib as maintenance therapy after first-line chemotherapy for advanced non-small cell lung cancer in China

H. Bai, J. Duan, Zhijie Wang, 2010 .

Phase 1/2 study of ceritinib in Chinese patients with advanced anaplastic lymphoma kinase-rearranged non-small cell lung cancer previously treated with crizotinib: Results from ASCEND-6.

Ying Cheng, C. Bai, Yi-long Wu, 2020, Lung cancer.

Positive expression of ERCC1 predicts a poorer platinum-based treatment outcome in Chinese patients with advanced non-small-cell lung cancer

L. Mao, Shuhang Wang, G. Feng, 2010, Medical oncology.

Significant Upregulation of HERV-K (HML-2) Transcription Levels in Human Lung Cancer and Cancer Cells

Lin Li, H. Wen, T. An, 2022, Frontiers in Microbiology.

High expression of ERCC1 is a poor prognostic factor in Chinese patients with non-small cell lung cancer receiving cisplatin-based therapy

H. Bai, J. Duan, Zhijie Wang, 2010 .

Survival comparison of right and left side non‐small cell lung cancer in stage I–IIIA patients: A Surveillance Epidemiology and End Results (SEER) analysis

F. Du, Hanxiao Chen, M. Zhuo, 2019, Thoracic cancer.

Rechallenge with pemetrexed-based chemotherapy improves the survival of patients with advanced non-squamous non-small-cell lung cancer.

H. Bai, M. Zhuo, J. Duan, 2014, Molecular and clinical oncology.

Characterization of Lung and Oral Microbiomes in Lung Cancer Patients Using Culturomics and 16S rRNA Gene Sequencing

Ruifu Yang, Yifan Sun, M. Zhuo, 2023, Microbiology spectrum.

Mechanistic Exploration of Cancer Stem Cell Marker Voltage-Dependent Calcium Channel α2δ1 Subunit-mediated Chemotherapy Resistance in Small-Cell Lung Cancer

Wei Zhao, Shuhang Wang, Hanxiao Chen, 2018, Clinical Cancer Research.

MA16.06 Phase I/II Study of AC0010, Mutant-Selective EGFR Inhibitor, in Non-Small Cell Lung Cancer (NSCLC) Patients with EGFR T790M Mutation

Ying Cheng, Yi-long Wu, Li Zhang, 2017 .

Characterization of Microbiota in Cancerous Lung and the Contralateral Non-Cancerous Lung Within Lung Cancer Patients

M. Zhuo, T. An, Ziping Wang, 2020, Frontiers in Oncology.

1例3次挑战培美曲塞方案治疗晚期非小细胞肺癌有效的个案报道

T. An, Yuyan Wang, J. Zhong, 2019, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Phosphorylated EGFR expression may predict outcome of EGFR-TKIs therapy for the advanced NSCLC patients with wild-type EGFR

Shuhang Wang, H. Bai, J. Duan, 2012, Journal of experimental & clinical cancer research : CR.

Retrospective analysis of the effectiveness and tolerability of nab‐paclitaxel in Chinese elderly patients with advanced non‐small‐cell lung carcinoma

Shuhang Wang, Hanxiao Chen, M. Zhuo, 2020, Thoracic cancer.

A phase II clinical trial of celecoxib combined with platinum-based regimen as first-line chemotherapy for advanced non-small cell lung cancer patients with cyclooxygenase-2 positive expression

H. Bai, J. Duan, Zhijie Wang, 2009 .

Effects of Surgery on Survival of Early-Stage Patients With SCLC: Propensity Score Analysis and Nomogram Construction in SEER Database

C. Gay, Jianjun Zhang, Hanxiao Chen, 2020, Frontiers in Oncology.

Efficacy and safety of weekly intravenous nanoparticle albumin‐bound paclitaxel for non‐small cell lung cancer patients who have failed at least two prior systemic treatments

H. Bai, M. Zhuo, J. Duan, 2017, Thoracic cancer.

[Effectiveness of Tyrosine Kinase Inhibitors on Uncommon Epidermal Growth Factor  Receptor Mutations in Non-small Cell Lung Cancer].

Hanxiao Chen, M. Zhuo, J. Duan, 2015, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Secreted proteins MDK, WFDC2, and CXCL14 as candidate biomarkers for early diagnosis of lung adenocarcinoma

M. Zhuo, Jun Zhao, T. An, 2023, BMC Cancer.

[Effectiveness of Tyrosine Kinase Inhibitors on Uncommon Epidermal Growth Factor  Receptor Mutations in Non-small Cell Lung Cancer].

Hanxiao Chen, M. Zhuo, J. Duan, 2015, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

An evaluation of phosphorylated EGFR expression in predicting outcome of EGFR-TKI therapy for the advanced NSCLC patients with EGFR wild type.

X. Liu, H. Bai, J. Duan, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Epidermal growth factor receptor genotype in plasma DNA and outcome of chemotherapy in the Chinese patients with advanced non-small cell lung cancer.

H. Bai, S. Song, M. Zhuo, 2011, Chinese Medical Journal.

Chemotherapy influence EGFR mutation status for Chinese patients with regionally advanced non-small cell lung cancer.

H. Bai, J. Duan, T. An, 2011, Journal of Clinical Oncology.

[The detection by denaturing high performance liquid chromatography of epidermal growth factor receptor mutation in tissue and peripheral blood from patients with advanced non-small cell lung cancer].

H. Bai, J. Duan, Jun Zhao, 2008, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases.